OKYO Pharma Ltd
OKYO- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001849296
In the last 90 days, OKYO Pharma Ltd insiders filed 7 open-market purchases and 0 sales; 19 institutions reported holding it in 13F filings for Q2 2026, worth $9.74M in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by OKYO Pharma Ltd insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 7 filings
- 6 insiders, $136.0K in total
- Open-market sells
- 0 filings
- Insiders trading
- 6
- Net value
- +$136.0K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for OKYO Pharma Ltd, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Brancaccio John P | Director | 35,201 | Aug 7, 2026 | 2 |
| Dempsey Robert John | CHIEF EXECUTIVE OFFICER | 15,000 | Aug 7, 2026 | 1 |
| Jacob Gary S | CHIEF DEVELOPMENT OFFICER | 112,420 | Aug 7, 2026 | 1 |
| Cerrone Gabriele M | Director, 10% Owner | 10,873,916Indirect | Aug 7, 2026 | 3 |
| Mantelli Flavio | CHIEF MEDICAL OFFICER | 20,000 | Aug 7, 2026 | 1 |
| Patil Rajkumar V. | Chief Scientific Officer | 20,030 | Aug 7, 2026 | 1 |
| Simon Willy Jules | Director | – | Jun 10, 2026 | 1 |
| Denoyer Bernard | Director | – | Jun 10, 2026 | 1 |
| Shah Keeren Rameshchandra | Chief Financial Officer | – | Jun 10, 2026 | 1 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 7, 2026 (view filing)4:15 PM ET | Jul 21 | 17 days | Brancaccio John PDirector | PPurchase | +5.00K | $1.48 | +$7.38K | +16.6%35.2K after | Amended |
| Aug 7, 2026 (view filing)4:15 PM ET | Jul 22 | 16 days | Dempsey Robert JohnCHIEF EXECUTIVE OFFICER | PPurchase | +15.0K | $1.54 | +$23.1K | New position15.0K after | Amended |
| Aug 7, 2026 (view filing)4:15 PM ET | Jul 21 | 17 days | Jacob Gary SCHIEF DEVELOPMENT OFFICER | PPurchase | +3.50K | $1.40 | +$4.90K | +3.2%112.4K after | Amended |
| Aug 7, 2026 (view filing)4:15 PM ET | Jul 21 | 17 days | Cerrone Gabriele MDirector, 10% Owner | PPurchase | +22.5K | $1.45 | +$32.6K | +0.2%10.9M after | Amended |
| Aug 7, 2026 (view filing)4:15 PM ET | Jul 20 | 18 days | Cerrone Gabriele MDirector, 10% Owner | PPurchase | +25.0K | $1.40 | +$35.0K | +0.2%10.9M after | Amended |
| Aug 7, 2026 (view filing)4:15 PM ET | Jul 21 | 17 days | Mantelli FlavioCHIEF MEDICAL OFFICER | PPurchase | +20.0K | $1.40 | +$28.0K | New position20.0K after | Amended |
| Aug 7, 2026 (view filing)4:15 PM ET | Jul 27 | 11 days | Patil Rajkumar V.Chief Scientific Officer | PPurchase | +3.36K | $1.49 | +$5.01K | +20.2%20.0K after | Amended |
| Sep 28, 2023 (view filing) | Sep 15 | 13 daysLate | Brancaccio John PDirector | PPurchase | +16.7K | $1.50 | +$25.0K | New position16.7K after | |
| May 20, 2022 (view filing)10:35 AM ET | May 19 | 1 day | Cerrone Gabriele MExecutive Chairman | PPurchase | +5.80M | $0.076 | +$440.8K | +1.1%549.0M after | |
| May 19, 2022 (view filing) | May 19 | Same day | Jacob Gary SChief Executive Officer | PPurchaseAmerican Depositary Shares | +12.5K | $4.00 | +$50.0K | New position12.5K after | |
| May 19, 2022 (view filing) | May 19 | Same day | Cerrone Gabriele MNon-Executive Chairman | PPurchaseAmerican Depositary Shares | +37.5K | $4.00 | +$150.0K | +150.0%62.5K after | |
| May 18, 2022 (view filing)11:37 AM ET | May 17 | 1 day | Cerrone Gabriele MNon-Executive Chairman | PPurchase | +1.63M | $0.0595 | +$96.7K | +0.3%544.8M after | |
| May 18, 2022 (view filing) | May 17 | 1 day | Cerrone Gabriele MNon-Executive Chairman | PPurchaseAmerican Depositary Shares | +25.0K | $3.87 | +$96.8K | New position25.0K after | Amended |